|
|
||||||||
The FASEB Journal, Vol 3, 2379-2388, Copyright © 1989 by The Federation of American Societies for Experimental Biology
REVIEWS |
SB Mizel
Department of Microbiology and Immunology, Wake Forest University Medical Center, Winston-Salem, North Carolina 27103.
The interactions between immune and inflammatory cells are mediated in large part by proteins, termed interleukins (IL), that are able to promote cell growth, differentiation, and functional activation. Seven interleukins have been described; each has unique biological activities as well as some that overlap with the others. Macrophages, cells that play important roles in both immunity and inflammation, produce IL 1 and IL 6, whereas T cells produce IL 2-IL 6 and bone marrow stromal cells produce IL 7. IL 1 and IL 6 not only play important roles in immune cell function, but also stimulate a spectrum of inflammatory cell types and induce fever. The growth and differentiation of eosinophils is markedly enhanced by IL 5. IL 2 is a potent proliferative signal for T cells, natural killer cells, and lymphokine- activated killer cells. IL 1, IL 3, IL 4, and IL 7 enhance the development of a variety of hematopoietic precursors. IL 4-IL 6 also serve to enhance B cell proliferation and antibody production. The understanding of interleukin structure and function has led to new and important insights into the fundamental biology of immunity and inflammation.
This article has been cited by other articles:
![]() |
R. van Minkelen, M. C.H. de Visser, J. J. Houwing-Duistermaat, H. L. Vos, R. M. Bertina, and F. R. Rosendaal Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the Risk of Venous Thrombosis Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1486 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Huang, Y. Wen, J. S. Kruessel, F. Raga, Y.-K. Soong, and M. L. Polan Interleukin (IL)-1{beta} Regulation of IL-1{beta} and IL-1 Receptor Antagonist Expression in Cultured Human Endometrial Stromal Cells J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1387 - 1393. [Abstract] [Full Text] |
||||
![]() |
D. F. Geffken, M. Cushman, G. L. Burke, J. F. Polak, P. A. Sakkinen, and R. P. Tracy Association between Physical Activity and Markers of Inflammation in a Healthy Elderly Population Am. J. Epidemiol., February 1, 2001; 153(3): 242 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aung and B. S. Graham IL-4 Diminishes Perforin-Mediated and Increases Fas Ligand-Mediated Cytotoxicity In Vivo J. Immunol., April 1, 2000; 164(7): 3487 - 3493. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. McKay, H. Y. Irie, G. Hollander, J. L. M. F. Ferrara, T. B. Strom, Y. Li, and S. J. Burakoff Antigen-Induced Unresponsiveness Results in Altered T Cell Signaling J. Immunol., December 15, 1999; 163(12): 6455 - 6461. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aung, Y.-W. Tang, and B. S. Graham Interleukin-4 Diminishes CD8+ Respiratory Syncytial Virus-Specific Cytotoxic T-Lymphocyte Activity In Vivo J. Virol., November 1, 1999; 73(11): 8944 - 8949. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-B. Haddad, J. Rousell, M. A. Lindsay, and P. J. Barnes Synergy between Tumor Necrosis Factor alpha and Interleukin 1beta in Inducing Transcriptional Down-regulation of Muscarinic M2 Receptor Gene Expression. INVOLVEMENT OF PROTEIN KINASE A AND CERAMIDE PATHWAYS J. Biol. Chem., December 20, 1996; 271(51): 32586 - 32592. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Liu, R. P. Hart, X.-J. Liu, W. Clevenger, R. A. Maki, and E. B. De Souza Cloning and Characterization of an Alternatively Processed Human Type II Interleukin-1 Receptor mRNA J. Biol. Chem., August 23, 1996; 271(34): 20965 - 20972. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |